1.Effect of nerve growth factor-gelatin sponge composite on peri-implant osseointegration.
Feng HUANG ; Li-xin XIANG ; Guo-chao XU
Chinese Journal of Stomatology 2013;48(1):23-26
OBJECTIVETo observe the peri-implant osseointegration after the application of exogenous nerve growth factor (NGF)-gelatin sponge (GS) composite.
METHODSSix beagle dogs were used to establish bi-mandible simultaneous implant model after the first and second premolar extraction. Then the dental implants were implanted into the distal socket while the bone defect was made in the mesial socket of each mandible. Then the NGF-GS was implanted into the defects as NGF-GS group, the gelatin sponge alone was implanted as GS control and the control group was left empty. Two dogs were sacrificed each time at 4 weeks, 8 weeks and 12 weeks postoperatively. Specimens were subjected to general observation, radiography, bone histological and histomorphometric analysis for the new bone formation. The data were analyzed with SPSS 11.5 software package.
RESULTSThe bone density in the defects around implants at 4 and 8 weeks postoperatively was lower than the normal bone. The bone-implant contact ratio in the NGF-GS group [(57.7 ± 6.4)%] was significantly higher than that in the GS control group and the control group [the ratio were (44.2 ± 3.3)% and (31.2 ± 3.1)%] (P < 0.01) at 4 weeks postoperatively, the bone-implant contact ratio in the GS control group was also significantly higher than that in the control group (P < 0.01) at that time. The bone-implant contact ratio in the NGF-GS group [(94.8 ± 7.7)%] was slightly higher than that in the GS control group and the control group [the ratio were (83.0 ± 4.1)% and (86.4 ± 6.3)%] at 8 weeks postoperatively, but there was no statistical difference (P > 0.05). The bone density in the defects around implants at 12 weeks was almost the same as the normal bone, there was no difference of the bone-implant contact ratio.
CONCLUSIONSNGF-GS application could increase new bone formation, accelerate maturation of trabecular bone around the implants and shorten the period of osseointegration.
Animals ; Dental Implantation, Endosseous ; methods ; Dental Implants ; Dogs ; Gelatin Sponge, Absorbable ; therapeutic use ; Male ; Nerve Growth Factor ; therapeutic use
2.The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma.
Korean Journal of Radiology 2009;10(5):425-434
Despite remarkable advancement in the surveillance and treatment of hepatocellular carcinoma (HCC) and the availability of novel curative options, a great proportion of HCC patients are still not eligible for curative treatment due to an advanced tumor stage or poor hepatic functional reserve. Therefore, there is a continuing need for effective palliative treatments. Although practiced widely, it has only recently been demonstrated that the use of transarterial chemoembolization (TACE) provides a survival benefit based on randomized controlled studies. Hence, TACE has become standard treatment in selected patients. TACE combines the effect of targeted chemotherapy with the effect of ischemic necrosis induced by arterial embolization. Most of the TACE procedures have been based on iodized oil utilizing the microembolic and drug-carrying characteristic of iodized oil. Recently, there have been efforts to improve the delivery of chemotherapeutic agents to a tumor. In this review, the basic principles, technical issues and complications of TACE are reviewed and recent advancement in TACE technique and clinical applicability are briefed.
Antineoplastic Agents/therapeutic use
;
Carcinoma, Hepatocellular/*therapy
;
Chemoembolization, Therapeutic/*methods
;
Gelatin Sponge, Absorbable/therapeutic use
;
Humans
;
Infusions, Intra-Arterial
;
Iodized Oil/therapeutic use
;
Liver Neoplasms/*therapy
3.Effect of injectable gelatin matrix as a hemostat for management of hepatic trauma in dogs under contrast-enhanced ultrasound guidance.
Xia XIE ; Jiangke TIAN ; Faqin LV ; Rong WU ; Wenbo TANG ; Yukun LUO ; Yaqin HUANG ; Jie TANG
Journal of Southern Medical University 2012;32(9):1260-1264
OBJECTIVETo explore the efficacy of injectable gelatin matrix as a hemostatic agent for treatment of grade III-IV hepatic trauma to a canine model with contrast-enhanced ultrasound (CEUS) guidance.
METHODSTwenty-seven healthy adult dogs underwent celiotomy in induce grade III-IV hepatic trauma in the left lateral lobe of the liver. The dogs were then randomized into 3 groups, namely the treatment group in which the injectable hemostat was percutaneously injected into the injury site under CEUS guidance, and the positive and negative control groups with thrombin solution and normal saline treatment, respectively. Intra-abdominal blood loss within 30 min postoperatively, and alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 7 days postoperatively were compared among the groups. Follow-up CEUS was performed in each animal 7 days after the operation.
RESULTSThe mean blood loss was 47.69 ml in the treatment group, significantly less than that in the positive control group (81.77 ml, P/0.01) and negative control group (110.35 ml, P<0.01). The treatment group had also significantly lower ALT and AST levels than the two control groups (ALT: 49.37, 62.81, and 82.83 U/L, respectively, P<0.05; AST: 48.32, 67.16, and 82.54 U/L, respectively, P<0.05). In the treatment group, CEUS did not detect hepatic lesions or ascites as found in the two control groups, and the perfusion of the liver was homogeneous.
CONCLUSIONThe injectable hemostat injected under the guidance of CEUS can effectively control grade III-IV hepatic hemorrhage in the canine model and show strong effects of stopping bleeding and promoting wound healing.
Animals ; Contrast Media ; Dogs ; Gelatin ; administration & dosage ; therapeutic use ; Hemostasis, Surgical ; Liver ; injuries ; Ultrasonography, Interventional
4.Hemodynamic effects of different fluid volumes for a fluid challenge in septic shock patients.
Ting YANG ; Li WENG ; Wei JIANG ; Shan LI ; Bin DU
Chinese Medical Journal 2022;135(6):672-680
BACKGROUND:
It is still unclear what the minimal infusion volume is to effectively predict fluid responsiveness. This study was designed to explore the minimal infusion volume to effectively predict fluid responsiveness in septic shock patients. Hemodynamic effects of fluid administration on arterial load were observed and added values of effective arterial elastance (Ea) in fluid resuscitation were assessed.
METHODS:
Intensive care unit septic shock patients with indwelling pulmonary artery catheter (PAC) received five sequential intravenous boluses of 100 mL 4% gelatin. Cardiac output (CO) was measured with PAC before and after each bolus. Fluid responsiveness was defined as an increase in CO >10% after 500 mL fluid infusion.
RESULTS:
Forty-seven patients were included and 35 (74.5%) patients were fluid responders. CO increasing >5.2% after a 200 mL fluid challenge (FC) provided an improved detection of fluid responsiveness, with a specificity of 80.0% and a sensitivity of 91.7%. The area under the ROC curve (AUC) was 0.93 (95% CI: 0.84-1.00, P < 0.001). Fluid administration induced a decrease in Ea from 2.23 (1.46-2.78) mmHg/mL to 1.83 (1.34-2.44) mmHg/mL (P = 0.002), especially for fluid responders in whom arterial pressure did not increase. Notably, the baseline Ea was able to detect the fluid responsiveness with an AUC of 0.74 (95% CI: 0.59-0.86, P < 0.001), whereas Ea failed to predict the pressure response to FC with an AUC of 0.50 (95% CI: 0.33-0.67, P = 0.086).
CONCLUSION:
In septic shock patients, a minimal volume of 200 mL 4% gelatin could reliably detect fluid responders. Fluid administration reduced Ea even when CO increased. The loss of arterial load might be the reason for patients who increased their CO without pressure responsiveness. Moreover, a high level of Ea before FC was able to predict fluid responsiveness rather than to detect the pressure responsiveness.
TRIAL REGISTRATION
ClinicalTrials.gov, NCT04515511.
Cardiac Output/physiology*
;
Fluid Therapy
;
Gelatin/therapeutic use*
;
Hemodynamics
;
Humans
;
Shock, Septic/therapy*
6.Huanglian Ejiao Decoction formula syndrome and its application for refractory insomnia.
China Journal of Chinese Materia Medica 2021;46(14):3732-3738
Huanglian Ejiao Decoction,firstly recorded in Treatise on Febrile Diseases,could be used to treat heat-conversion syndrome of Shaoyin. It has been identified that,the indications of Huanglian Ejiao Decoction include:(1)in modern medicine,it can be used to treat insomnia,arrhythmia,oral ulcer,Xiali,blood syndrome and other diseases;(2)in terms of symptoms and signs,it is mainly used for restlessness,ritability,insomnia,extremely difficult to fall asleep,palpitation,atrial premature beat,ventricular premature beat and other arrhythmias,stomach distension and stuffiness,stomach pain,vomiting,abdominal pain,cramps,lower edge,constipation,blush,red lips,easy bleeding,red tongue,thin or no coating,dry tongue surface,or light red tongue,or dark red,thin white tongue coating,and rapid pulse. It has been also identified that,(1)although the original statement of Huanglian Ejiao Decoction is very simple,it can not only be used according to irritability and insomnia;(2)tongue image is not the key to syndrome differentiation of this prescription;(3)the essence of Shaoyin syndrome is not completely heart kidney Yang deficiency,which is closest to shock in modern medicine,including septic shock,hypovolemic shock and cardiogenic shock;(4)the essential difference between Shaoyin cold and heat conversion syndrome of Shaoyin lies in the different types of shock,in which cardiogenic shock is the main cold type,while septic shock is the main heat shock;(5)heat-conversion syndrome of Shaoyin is more common in the late stage of septic shock,and part of it can be seen in the stage of heart failure combined with sympathetic activation;(6)Dioscoreae Rhizoma and Rehmanniae Radix are often used to replace egg yolk;(7)Huanglian Ejiao Decoction takes effect quickly and the course of treatment is short.
Drugs, Chinese Herbal/therapeutic use*
;
Gelatin
;
Humans
;
Medicine, Chinese Traditional
;
Sleep Initiation and Maintenance Disorders/drug therapy*
;
Yang Deficiency
7.Haemostatic agents of the gelatin matrix for a large liver wound by percutaneous injection without pressure under the guidance of contrast-enhanced ultrasound.
Teng-fei YU ; Fa-qin LÜ ; Zhi-yan LI ; Ling LIU ; Qiang LIU ; Ai-jun LIU ; Ya-qin HUANG ; Jie TANG
Chinese Medical Journal 2011;124(9):1352-1356
BACKGROUNDThe non-operation treatment of intra-abdominal trauma guided contrast enhanced ultrasound (CEUS) is one of the hottest research topic. Gelatin/thrombin/calcium (GTC) was developed as a novel haemostatic agent for non-operable intra-abdominal trauma. We hypothesized that GTC can achieve haemostasis (without the use of pressure) within a short time in a large wound model by percutaneous injection under CEUS guidance.
METHODSForty Wister rats received large liver injuries by haemostatic clamp and were randomly divided into four groups, according to the haemostatic agent used. These included normal saline (NS) group A, lyophilising thrombin powder (LTP) group B, GTC group C, and absorbable α-cyanoacrylate (ACNA) group D. Each injury site was treated with one of the above materials and total bleeding time was recorded. All liver wounds were evaluated using CEUS at three periods: pre-injury, injury and post-treatment. The liver wounds were also evaluated by histology 3, 6, and 9 days after injury and the extents of abdominal adhesions were recorded.
RESULTSThe sensitivity of CEUS (100%) in detecting blunt traumatic liver lesions was significantly higher than conventional ultrasound (42.5%). Bleeding times at the injury site in the GTC group C ((129.3 ± 14.0) seconds) and ACNA group D ((5.2 ± 1.0) seconds) were significantly shorter than those in the NS group A ((369.5 ± 48.8) seconds, P < 0.01) and LTP group B ((324.7 ± 52.22) seconds, P < 0.01). The LTP group B showed no significant difference compared with the NS group A. Gross examination of liver tissue revealed that there were fewer intra-abdominal adhesions in the GTC group C (10%) than in the ACNA group D (100%). Histopathologic examination showed that GTC was completely absorbed after nine days.
CONCLUSIONSGTC, delivered by percutaneous injection under CEUS, may achieve haemostasis (without the use of pressure) within a short time in a large wound model. GTC is absorbable and may prevent intra-abdominal adhesions. Therefore, it may be the optimal choice for first aid treatment of large abdominal wounds in the setting of blunt trauma.
Animals ; Calcium ; administration & dosage ; therapeutic use ; Gelatin ; administration & dosage ; therapeutic use ; Hemorrhage ; diagnostic imaging ; drug therapy ; Hemostatics ; administration & dosage ; therapeutic use ; Injections ; Liver ; diagnostic imaging ; injuries ; Male ; Random Allocation ; Rats ; Rats, Wistar ; Thrombin ; administration & dosage ; therapeutic use ; Ultrasonography
8.Comparison of the Effectiveness of Embolic Agents for Bronchial Artery Embolization: Gelfoam versus Polyvinyl Alcohol.
Seok HAHN ; Young Ju KIM ; Woocheol KWON ; Seung Whan CHA ; Won Yeon LEE
Korean Journal of Radiology 2010;11(5):542-546
OBJECTIVE: The purpose of this study was to compare the results of different agents for bronchial artery embolization of hemoptysis. MATERIALS AND METHODS: From March 1992 to December 2006, a bronchial artery embolization was performed on 430 patients with hemoptysis. The patients were divided into three groups. Group 1 included 74 patients treated with a gelfoam particle (1x1x1 mm), while group 2 comprised of 205 patients treated with polyvinyl alcohol (PVA) at 355-500 micrometer, and group 3 included 151 patients treated with PVA at 500-710 micrometer. We categorized the results as technical and clinical successes, and also included the mid-term results. Retrospectively, the technical success was compared immediately after the procedure. The clinical success and mid-term results (percentage of patients who were free of hemoptysis) were compared at 1 and 12 months after the procedure, respectively. RESULTS: Neither the technical successes (group 1; 85%, 2; 85%, 3; 90%) nor the clinical successes (group 1; 72%, 2; 74%, 3; 71%) showed a significant difference among the 3 groups (p > 0.05). However, the mid-term results (group 1; 45%, 2; 63%, 3; 62%) and mid-term results excluding the recurrence from collateral vessels in each of the groups (group 1; 1 patient, 2; 4 patients, 3; 2 patients) showed that group 1 was lower than the other two groups (p < 0.05). No significant difference was discovered for the mid-term results between groups 2 and 3. Moreover, the same results not including incidences of recurrence from collateral vessels also showed no statistical significance between the two groups (p > 0.05). CONCLUSION: Polyvinyl alcohol appears to be the more optimal modality compared to gelfoam particle for bronchial artery embolization in order to improve the mid-term results. The material size of PVA needs to be selected to match with the vascular diameter.
Adolescent
;
Adult
;
Aged
;
Angiography
;
*Bronchial Arteries
;
Embolization, Therapeutic/*methods
;
Female
;
Gelatin Sponge, Absorbable/*therapeutic use
;
Hemoptysis/etiology/radiography/*therapy
;
Hemostatics/*therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Polyvinyl Alcohol/*therapeutic use
;
Treatment Outcome
10.Renal and Splenic Micro-Infarctions Following Bronchial Artery Embolization with Tris-Acryl Microspheres.
Ka Fai Johnny MA ; Wing Hang WONG ; Choi Yu Dilys LUI ; Lik Fai CHENG
Korean Journal of Radiology 2009;10(1):97-99
A bronchial artery embolization (BAE) is an important therapeutic method used to control acute and chronic hemoptysis. We report a case of multiple micro-infarcts involving both the kidneys and spleen, following a BAE with 500-700 micrometer crossed-linked tris-acryl microspheres (Embospheres) in a patient with bronchial artery pulmonary vein shunts. The superior penetration characteristics of the microspheres may have resulted in the greater tendency to cross the bronchial artery pulmonary vein shunts, which subsequently caused the systemic infarcts in our patient. We propose the use of larger sized microspheres (700-900 micrometer), which may aid in avoiding this complication.
Acrylic Resins/*adverse effects/therapeutic use
;
Adult
;
*Bronchial Arteries
;
Embolization, Therapeutic/*adverse effects
;
Female
;
Gelatin/*adverse effects/therapeutic use
;
Hemoptysis/therapy
;
Humans
;
Infarction/*etiology/radiography
;
Kidney/*blood supply
;
Splenic Infarction/*etiology/radiography